IRIS - Res&Arch Institutional Research Information System - Research & Archive

DE SOCIO, GIUSEPPE VITTORIO LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.765
AS - Asia 3.042
EU - Europa 1.744
SA - Sud America 1.055
Continente sconosciuto - Info sul continente non disponibili 342
AF - Africa 115
OC - Oceania 2
Totale 10.065
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.569
SG - Singapore 1.213
BR - Brasile 778
VN - Vietnam 465
CN - Cina 409
IT - Italia 398
HK - Hong Kong 276
RU - Federazione Russa 253
KR - Corea 198
IE - Irlanda 194
FR - Francia 184
DE - Germania 156
SE - Svezia 141
UA - Ucraina 124
BD - Bangladesh 101
GB - Regno Unito 98
AR - Argentina 93
CA - Canada 86
IN - India 72
FI - Finlandia 66
TR - Turchia 57
EC - Ecuador 54
MX - Messico 51
ID - Indonesia 44
CO - Colombia 39
IQ - Iraq 38
VE - Venezuela 30
AT - Austria 26
ZA - Sudafrica 26
SA - Arabia Saudita 20
JP - Giappone 19
PK - Pakistan 19
NL - Olanda 18
PL - Polonia 18
UZ - Uzbekistan 17
CL - Cile 16
MA - Marocco 16
CR - Costa Rica 15
PY - Paraguay 15
PH - Filippine 14
SC - Seychelles 14
ES - Italia 13
PE - Perù 13
EG - Egitto 12
LB - Libano 12
JO - Giordania 10
AE - Emirati Arabi Uniti 9
BO - Bolivia 9
JM - Giamaica 9
MY - Malesia 8
KE - Kenya 7
RO - Romania 7
BE - Belgio 6
DZ - Algeria 6
GR - Grecia 6
UY - Uruguay 6
AL - Albania 5
EE - Estonia 5
GA - Gabon 5
IL - Israele 5
LT - Lituania 5
PS - Palestinian Territory 5
SV - El Salvador 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
BH - Bahrain 4
ET - Etiopia 4
GT - Guatemala 4
HN - Honduras 4
OM - Oman 4
TH - Thailandia 4
TN - Tunisia 4
BZ - Belize 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
KW - Kuwait 3
KZ - Kazakistan 3
PR - Porto Rico 3
SD - Sudan 3
SN - Senegal 3
AU - Australia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
HU - Ungheria 2
LY - Libia 2
MD - Moldavia 2
ML - Mali 2
MU - Mauritius 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
PT - Portogallo 2
RS - Serbia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
Totale 9.704
Salva come PNG Salva come JPEG
Città #
Singapore 798
San Jose 404
Ashburn 370
Hong Kong 273
Council Bluffs 246
Seoul 197
Chandler 194
Dublin 193
Ho Chi Minh City 154
Santa Clara 134
Lauterbourg 128
Columbus 101
Piscataway 98
New York 95
Moscow 92
San Mateo 86
Beijing 85
Los Angeles 82
Hanoi 81
São Paulo 78
Dong Ket 67
Boardman 63
Perugia 62
Jacksonville 58
Munich 55
Altamura 54
Princeton 49
Medford 45
Dallas 39
Wilmington 39
Lawrence 38
Ann Arbor 33
Rio de Janeiro 33
Hefei 31
The Dalles 30
Helsinki 26
Montreal 26
Riverbank 26
Charlotte 25
Des Moines 25
North Bergen 25
Milan 24
Buffalo 23
Mexico City 23
New Orleans 23
Nuremberg 22
Frankfurt am Main 21
Rome 21
Falls Church 20
Haiphong 20
Atlanta 19
Phoenix 19
Toronto 19
Florence 18
Houston 18
Orem 18
Tokyo 18
Andover 17
Guayaquil 17
Brooklyn 16
Chennai 16
Curitiba 16
Denver 16
Baghdad 15
Turku 15
Amsterdam 14
London 14
Brasília 13
Quito 13
San José 13
Vienna 13
Warsaw 13
Caracas 12
Medellín 12
Padova 12
Porto Alegre 12
Riyadh 12
Tashkent 12
Ankara 11
Belo Horizonte 11
Chicago 11
Guangzhou 11
Guarulhos 11
Ninh Bình 11
Poplar 11
Woodbridge 11
Bologna 10
Boston 10
Falkenstein 10
Izmir 10
Norwalk 10
Salvador 10
Campinas 9
Da Nang 9
Dhaka 9
Johannesburg 9
Manaus 9
Mersin 9
Miami 9
Philadelphia 9
Totale 5.577
Salva come PNG Salva come JPEG
Nome #
Accelerate Pheno™ system in sepsis by Gram-negative pathogens: four months of hospital experience 180
Aortic stiffness in untreated adult patients with human immunodeficiency virus infection. 157
Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection 156
Accelerate Pheno™ blood culture detection system: a literature review 156
Achromobacter denitrificans renal abscess. 137
Impact of treatment with protease inhibitors on aortic stiffness in adult patients with human immunodeficiency virus infection. 134
Measurement and prediction of antimicrobial resistance in bloodstream infections by ESKAPE pathogens and Escherichia coli 131
Acute cytomegalovirus meningomyelitis in an immunocompetent patient. 128
Partial achievement of the 90-90-90 UNAIDS target in a cohort of HIV infected patients from Central Italy 123
Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia A Randomized Clinical Trial 119
Accuracy and impact on patient management of new tools for diagnosis of sepsis: Experience with the t2 magnetic resonance bacteria panel 117
Impact of treatment with protease inhibitors on aortic stiffness in adult patients with human immunodeficiency virus infection. 116
National Early Warning Score 2 (NEWS2) better predicts critical Coronavirus Disease 2019 (COVID-19) illness than COVID-GRAM, a multi-centre study 114
Smoking Habits in Human Immunodeficiency Virus-Infected People from Italy: A Cross-Sectional Analysis of the STOPSHIV Cohort 112
Pre and Post-Monoclonal Infusion Neutralizing Activity in a Subgroup of Patients Treated in the Presence of two SARS-CoV-2 Dominant Variant of Concern (VOCs) and an Ongoing Vaccination. Overall Clinical Efficacy of Two Monoclonal Antibodies Association in Umbria 110
Hepatitis C virus genotypes in the liver and serum of patients with chronic hepatitis C 109
Delivery in asymptomatic Italian woman with SARS-CoV-2 infection 107
XVI Convegno Nazionale AIDS e SINDROMI CORRELATE 105
Prevalence of smoking and nicotine dependence in HIV patients, the project STOPS HIV from Italy 105
[Loa loa filariasis in Italy: review of the literature with a clinical report] 103
Evaluation of IVD 3.0 Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of Mycobacterium tuberculosis and nontuberculous mycobacteria and its use in routine diagnostics. 102
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: A cross-sectional study 100
Semiquantitative PCR in the diagnosis of HIV infection: correlation to clinical stage and serological status. 97
Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients 97
Bictegravir/Tenofovir Alafenamide/Emtricitabine: A Real-Life Experience in People Living with HIV (PLWH) 95
Early treatment with bamlanivimab alone does not prevent COVID-19 hospitalization and its post-acute sequelae. A real experience in Umbria, Italy 94
Smoking habits in HIV-infected people compared with the general population in Italy: A cross-sectional study 93
Infezioni da Cytomegalovirus nel paziente immunodepresso. 91
Le infezioni da Cytomegalovirus ed il loro trattamento nel paziente immunodepresso (AIDS e TMO). 90
Decreasing cardiovascular risk in HIV infection between 2005 and 2011. 88
Is it feasible to impact on smoking habits in HIV-Infected patients? Mission impossible from the STOPSHIV Project cohort 87
Lingual tubercolosis: a rare disease in western countries 86
Negative influence of HIV infection on day-night blood pressure variability. 85
Laboratory automation reduces time to report of positive blood cultures and improves management of patients with bloodstream infection 84
Improving the etiological diagnosis of osteoarticular infections with the commercial multiplex real-time polymerase chain reaction SeptiFast® 84
An unusual case of epigastric and back pain: expanding descending thoracic aneurysm resulting from tertiary syphilis diagnosed with positron emission tomography. 80
Dolutegravir/Lamivudine versus Tenofovir Alafenamide/Emtricitabine/Bictegravir as a Switch Strategy in a Real-Life Cohort of Virogically Suppressed People Living with HIV 79
Efficacy and Tollerability of INI-Based 2-Drug Regimen in Virosuppressed Persons Living with HIV: A Systematic Review and Meta-Analysis 75
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 75
HIV infection and antiretroviral treatment: a "two-hit" model for arterial stiffness? 73
Impact of smoking habits on cardiovascular and neoplastic events and all-cause death in people living with HIVfrom the STOPSHIV cohort 71
Trajectories of CD4+/CD8+ T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study 71
Fusobacterium nucleatum endocarditis mimicking polymyalgia rheumatica 70
Observed versus predicted cardiovascular events and all-cause death in HIV infection: A longitudinal cohort study 70
Laboratory automation, informatics, and artificial intelligence: current and future perspectives in clinical microbiology 68
Retroperitoneal abscess: an uncommon localization of tubercular infection. 67
AmBisome administration for Candida albicans shunt infections 65
Screening for Latent Tuberculosis Infection in People Living with HIV: TUBHIVIT Project, a Multicenter Italian Study 64
Bictegravir and Dolutegravir have no impact on glucose levels 12 months after initiation 64
[Renal toxicity in HIV-infected patients receiving HAART including tenofovir] 63
Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade 62
Liver enzyme variation after switching to emtricitabine/tenofovir alafenamide/bictegravir is associated with glucose increase in a real-life cohort 61
Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project 61
Use of a molecular syndromic panel for the etiological diagnosis of ventilator-associated bacterial pneumonia: impact on clinical outcomes and antibiotic use from a multicenter, prospective study 61
Real-life monocentric Biktarvy cohort from Perugia 60
Antiretroviral therapy and adverse skeletal effects 60
Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting 60
Giant Infective Endocarditis of Native Aortic Valve with Secondary Mitral Kissing Vegetation 60
Symmetric ambulatory arterial stiffness index and 24-h pulse pressure in HIV infection: results of a nationwide cross-sectional study 60
Ageing with HIV: a multidisciplinary review 59
Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: the HIV and Hypertension Study 58
Polypharmacy, anticholinergic burden and drug-drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry 58
Hypophosphatemic Osteomalacia Associated with Tenofovir: a Multidisciplinary Approach is Required 57
A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks' observational data 57
Thrombocytopenia in HIV infected patients: prevalence and clinical spectrum 57
[Low incidence of streptococcal pharyngitis in young adults] 56
Lack of HIV seroconversion in a patient treated immediately with antiretroviral therapy at acute infection and virus relapse 56
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry 55
A study of SARS-CoV-2 epidemiology in Italy: from early days to secondary effects after social distancing 55
The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years 54
Real-life safety of Emtricitabine/Tenofovir Alafenamide/Bictegravir 54
Prevalence, awareness, treatment, and control rate of hypertension in HIV-infected patients: the HIV-HY study. 54
Effectiveness, safety and tolerability of dolutegravir/lamivudine versus tenofovir alafenamide/emtricitabine/bictegravir in a real-life cohort of HIV-1 virologically suppressed treatment experienced people living with HIV 54
96 Week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: a multicentre Italian experience 54
Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 53
HIV Infection - Screening, Diagnosis, and Treatment 53
Reversibility of Central Nervous System Adverse Events in Course of Art 53
Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry 52
Knowledge of STIs and HIV among people with and without HIV: where are we now? 52
Relations between cardiovascular risk estimates and subclinical atherosclerosis in naı¨ve HIV patients: results from the HERMES study 51
UV-C Irradiation Effectiveness on Mpox-Virus-Contaminated Surfaces 51
Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study 51
People with HIV pioneers of injectable cabotegravir and rilpivirine long acting in Italy: who are they? 50
Factors Associated With Weight Gain in People Treated With Dolutegravir 50
Lipids and Body Mass Index in Antiretroviral-Experienced People With HIV on Doravirine-Based Treatments: A Comparison Between Dual or Triple Regimen Versus Bictegravir-Based Triple Regimen 50
Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study 49
The use of nucleoside reverse transcriptase inhibitors sparing regimens in treatment-experienced HIV-1 infected patients 48
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA Project 48
Alexithymia Predicts Carotid Atherosclerosis, Vascular Events, and All-Cause Mortality in Human Immunodeficiency Virus-Infected Patients: An Italian Multisite Prospective Cohort Study 48
Adefovir induced hypophosphatemic osteomalacia 47
Schizophrenia, drug therapy, and monitoring 47
Use of statins and aspirin to prevent cardiovascular disease among HIV-positive patients. A survey among Italian HIV physicians 47
Weight Gain: A Possible Side Effect of All Antiretrovirals 46
Safety and efficacy of switching people with HIV to dual treatment with 3TC/DTG and RPV/DTG in real life: results from the SCOLTA cohort 46
Knowledge of Sexually Transmitted Infections and HIV among People Living with HIV: Should We Be Concerned? 45
Is metabolic syndrome associated to HIV infection per se? Results from the HERMES study 45
Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort 45
Waist circumference and body mass index in HIV infection 45
Risk of Cardiovascular Events in People with HIV (PWH) Treated with Integrase Strand-Transfer Inhibitors: The Debate Is Not Over; Results of the SCOLTA Study 44
Role of Normalized T-Cell Subsets in Predicting Comorbidities in a Large Cohort of Geriatric HIV-Infected Patients 44
Totale 7.590
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.529
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.529
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022285 0 0 0 25 18 15 7 91 13 13 47 56
2022/2023675 48 130 11 54 44 83 9 23 246 0 16 11
2023/2024267 11 32 14 5 4 1 69 3 23 11 50 44
2024/20251.322 9 66 24 28 78 48 54 55 216 278 200 266
2025/20265.109 314 389 450 1.176 425 234 620 317 497 413 181 93
2026/20271.732 128 242 307 1.055 0 0 0 0 0 0 0 0
Totale 10.065